Head-to-head · computed 2026-08-11
LifeMD vs PlexusDx
LifeMD: LifeMD attaches a $149/month program fee to medication pricing; its compounded tirzepatide all-in figure ($597) is the highest in our index, though its insurance-navigation pathway for brand products is a genuine strength. PlexusDx: PlexusDx sells flat-rate compounded protocols with no membership: $149/month semaglutide injection (flat from 0.25 to 2.0 mg weekly), $249/month tirzepatide injection (flat from 2.5 to 15 mg), a $129/month microdose protocol, and an optional genetic test the company positions as personalization.
Tirzepatide
| LifeMD | PlexusDx | |
|---|---|---|
| All-in maintenance | $597/mo | $249/mo |
| Best plan rate | $597/mo | $249/mo |
| 12-month total | $7,164 | $2,988 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-11 |
The arithmetic
On the figures our desk holds, PlexusDx's $249 a month undercuts LifeMD's $597 by $348 a month at the 10 mg/wk maintenance basis — $4,176 across a year. PlexusDx's figure is provider-stated (captured 2026-08-11) and LifeMD's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
LifeMD's tirzepatide ladder runs $597 a month billed monthly. PlexusDx's runs $249 a month billed monthly. On the twelve-month basis PlexusDx's $2,988 beats LifeMD's $7,164 by $4,176 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| LifeMD | PlexusDx | |
|---|---|---|
| All-in maintenance | $348/mo | $149/mo |
| Best plan rate | $348/mo | $149/mo |
| 12-month total | $4,176 | $1,788 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-11 |
The arithmetic
On the figures our desk holds, PlexusDx's $149 a month undercuts LifeMD's $348 by $199 a month at the 2.4 mg/wk maintenance basis — $2,388 across a year. PlexusDx's figure is provider-stated (captured 2026-08-11) and LifeMD's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
LifeMD's semaglutide ladder runs $348 a month billed monthly. PlexusDx's runs $149 a month billed monthly. On the twelve-month basis PlexusDx's $1,788 beats LifeMD's $4,176 by $2,388 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
PlexusDx carries no membership fee against LifeMD's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On verifiability, LifeMD names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while PlexusDx's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice. LifeMD works with insurance pathways while PlexusDx is cash-pay only — decisive if you hold coverage worth using (the indication doors map when you do), irrelevant if you're paying cash either way.
Structure, side by side
LifeMD
- Membership$149/mo
- Dose policyFlat at published rate
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
PlexusDx
- MembershipNone
- Dose policyDose-flat per published protocol pricing (semaglutide flat across five dose levels; tirzepatide flat across six)
- CommitmentMonth-to-month
- CancellationPer published terms; confirm at checkout
- PharmacyLicensed 503A compounders (per company; names undisclosed on captured materials)
What our desk is watching on each
LifeMD: Highest all-in compounded tirzepatide in the index; the value case rests on clinical service and insurance help, not price.
PlexusDx: Provider-stated throughout: every figure here comes from PlexusDx's own published materials, which the company distributes inside competitor 'reviews' on its blog — a marketing format worth noting even when the numbers are consistent. The optional 'Precision Peptide Genetic Test' is an upsell whose clinical utility for dose selection is not established by the class's trial record; the microdose protocol is sub-maintenance by design and is not ranked at the maintenance basis. Pharmacy names undisclosed on captured materials — the verification workflow stalls at step one until answered. Independent checkout capture pending.
Questions people ask
Is LifeMD or PlexusDx cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does LifeMD vs PlexusDx miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do LifeMD and PlexusDx cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $7,164 at LifeMD and $2,988 at PlexusDx — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: LifeMD · PlexusDx. Official sites: LifeMD ↗ · PlexusDx ↗. Nothing here is medical advice.